Despite the availability of multiple pharmacological options, including rapid-acting insulin analogs, postprandial hyperglycemia is highly prevalent in patients with both type 1 diabetes and type 2 diabetes [13,14]. The gene discussed is INS; the disease is type 1 diabetes mellitus.